Implanet entrusts its Listing Sponsor contract to the company Atout Capital


(AOF) – Implanet, a medical technology company specializing in implants intended for orthopedic surgery and in the distribution of technological medical equipment, announces that it has entrusted its Listing Sponsor contract to the company Atout Capital. This contract took effect on January 1, 2024 for a period of 2 years. The group will communicate its 2023 annual turnover on January 15, 2024 after market close.

© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group

Did you like this article ? Share it with your friends using the buttons below.





Facebook


Linkedin


E-mail





Source link -85